ArticleKidney international reports2025

Complement Inhibition Enables Antivascular Endothelial Growth Factor Receptor Therapy in Renal-Limited Thrombotic Microangiopathy.

Elena-Bianca Barbir et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.